The global Anticonvulsant Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anticonvulsant Drug include GlaxoSmithKline Plc, Astellas Pharma Technologies, Valeant Pharmaceuticals N.A, Bausch Health Companies, Watson Laboratories, Abbott Laboratories, Teva Pharmaceutical Industries, Johnson & Johnson and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
The anticonvulsant drug is a type of drug that is used to prevent or treat seizures or convulsions by controlling abnormal electrical activity in the brain.
This report aims to provide a comprehensive presentation of the global market for Anticonvulsant Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticonvulsant Drug. This report contains market size and forecasts of Anticonvulsant Drug in global, including the following market information:
Global Anticonvulsant Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anticonvulsant Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anticonvulsant Drug companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticonvulsant Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticonvulsant Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anticonvulsant Drug Market Segment Percentages, by Type, 2022 (%)
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
Barbiturate
Benzodiazepine
Carbamate Anticonvulsants
Carbonic Anhydrase Inhibitor
Dibenzazepine
Triazine
Global Anticonvulsant Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anticonvulsant Drug Market Segment Percentages, by Application, 2022 (%)
Anxiety
Bipolar Disorder
Borderline Personality Disorder
Epilepsy
Fibromyalgia
Migraine
Neuropathic Pain
Others
Global Anticonvulsant Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anticonvulsant Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticonvulsant Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anticonvulsant Drug revenues share in global market, 2022 (%)
Key companies Anticonvulsant Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anticonvulsant Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Plc
Astellas Pharma Technologies
Valeant Pharmaceuticals N.A
Bausch Health Companies
Watson Laboratories
Abbott Laboratories
Teva Pharmaceutical Industries
Johnson & Johnson
Novartis AG
Pfizer
Shire Plc
UCB Group
Huazhong Pharmaceutical Company Limited
Changzhou Siyao Pharmaceutical
Shandong Xinyi Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticonvulsant Drug, market overview.
Chapter 2: Global Anticonvulsant Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Anticonvulsant Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticonvulsant Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anticonvulsant Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Anticonvulsant Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticonvulsant Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticonvulsant Drug Overall Market Size
2.1 Global Anticonvulsant Drug Market Size: 2022 VS 2029
2.2 Global Anticonvulsant Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anticonvulsant Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Anticonvulsant Drug Players in Global Market
3.2 Top Global Anticonvulsant Drug Companies Ranked by Revenue
3.3 Global Anticonvulsant Drug Revenue by Companies
3.4 Global Anticonvulsant Drug Sales by Companies
3.5 Global Anticonvulsant Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anticonvulsant Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anticonvulsant Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anticonvulsant Drug Players in Global Market
3.8.1 List of Global Tier 1 Anticonvulsant Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anticonvulsant Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anticonvulsant Drug Market Size Markets, 2022 & 2029
4.1.2 α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
4.1.3 Barbiturate
4.1.4 Benzodiazepine
4.1.5 Carbamate Anticonvulsants
4.1.6 Carbonic Anhydrase Inhibitor
4.1.7 Dibenzazepine
4.1.8 Triazine
4.2 By Type - Global Anticonvulsant Drug Revenue & Forecasts
4.2.1 By Type - Global Anticonvulsant Drug Revenue, 2018-2023
4.2.2 By Type - Global Anticonvulsant Drug Revenue, 2024-2029
4.2.3 By Type - Global Anticonvulsant Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Anticonvulsant Drug Sales & Forecasts
4.3.1 By Type - Global Anticonvulsant Drug Sales, 2018-2023
4.3.2 By Type - Global Anticonvulsant Drug Sales, 2024-2029
4.3.3 By Type - Global Anticonvulsant Drug Sales Market Share, 2018-2029
4.4 By Type - Global Anticonvulsant Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anticonvulsant Drug Market Size, 2022 & 2029
5.1.2 Anxiety
5.1.3 Bipolar Disorder
5.1.4 Borderline Personality Disorder
5.1.5 Epilepsy
5.1.6 Fibromyalgia
5.1.7 Migraine
5.1.8 Neuropathic Pain
5.1.9 Others
5.2 By Application - Global Anticonvulsant Drug Revenue & Forecasts
5.2.1 By Application - Global Anticonvulsant Drug Revenue, 2018-2023
5.2.2 By Application - Global Anticonvulsant Drug Revenue, 2024-2029
5.2.3 By Application - Global Anticonvulsant Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Anticonvulsant Drug Sales & Forecasts
5.3.1 By Application - Global Anticonvulsant Drug Sales, 2018-2023
5.3.2 By Application - Global Anticonvulsant Drug Sales, 2024-2029
5.3.3 By Application - Global Anticonvulsant Drug Sales Market Share, 2018-2029
5.4 By Application - Global Anticonvulsant Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anticonvulsant Drug Market Size, 2022 & 2029
6.2 By Region - Global Anticonvulsant Drug Revenue & Forecasts
6.2.1 By Region - Global Anticonvulsant Drug Revenue, 2018-2023
6.2.2 By Region - Global Anticonvulsant Drug Revenue, 2024-2029
6.2.3 By Region - Global Anticonvulsant Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Anticonvulsant Drug Sales & Forecasts
6.3.1 By Region - Global Anticonvulsant Drug Sales, 2018-2023
6.3.2 By Region - Global Anticonvulsant Drug Sales, 2024-2029
6.3.3 By Region - Global Anticonvulsant Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anticonvulsant Drug Revenue, 2018-2029
6.4.2 By Country - North America Anticonvulsant Drug Sales, 2018-2029
6.4.3 US Anticonvulsant Drug Market Size, 2018-2029
6.4.4 Canada Anticonvulsant Drug Market Size, 2018-2029
6.4.5 Mexico Anticonvulsant Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anticonvulsant Drug Revenue, 2018-2029
6.5.2 By Country - Europe Anticonvulsant Drug Sales, 2018-2029
6.5.3 Germany Anticonvulsant Drug Market Size, 2018-2029
6.5.4 France Anticonvulsant Drug Market Size, 2018-2029
6.5.5 U.K. Anticonvulsant Drug Market Size, 2018-2029
6.5.6 Italy Anticonvulsant Drug Market Size, 2018-2029
6.5.7 Russia Anticonvulsant Drug Market Size, 2018-2029
6.5.8 Nordic Countries Anticonvulsant Drug Market Size, 2018-2029
6.5.9 Benelux Anticonvulsant Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anticonvulsant Drug Revenue, 2018-2029
6.6.2 By Region - Asia Anticonvulsant Drug Sales, 2018-2029
6.6.3 China Anticonvulsant Drug Market Size, 2018-2029
6.6.4 Japan Anticonvulsant Drug Market Size, 2018-2029
6.6.5 South Korea Anticonvulsant Drug Market Size, 2018-2029
6.6.6 Southeast Asia Anticonvulsant Drug Market Size, 2018-2029
6.6.7 India Anticonvulsant Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anticonvulsant Drug Revenue, 2018-2029
6.7.2 By Country - South America Anticonvulsant Drug Sales, 2018-2029
6.7.3 Brazil Anticonvulsant Drug Market Size, 2018-2029
6.7.4 Argentina Anticonvulsant Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anticonvulsant Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anticonvulsant Drug Sales, 2018-2029
6.8.3 Turkey Anticonvulsant Drug Market Size, 2018-2029
6.8.4 Israel Anticonvulsant Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Anticonvulsant Drug Market Size, 2018-2029
6.8.6 UAE Anticonvulsant Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline Plc
7.1.1 GlaxoSmithKline Plc Company Summary
7.1.2 GlaxoSmithKline Plc Business Overview
7.1.3 GlaxoSmithKline Plc Anticonvulsant Drug Major Product Offerings
7.1.4 GlaxoSmithKline Plc Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Plc Key News & Latest Developments
7.2 Astellas Pharma Technologies
7.2.1 Astellas Pharma Technologies Company Summary
7.2.2 Astellas Pharma Technologies Business Overview
7.2.3 Astellas Pharma Technologies Anticonvulsant Drug Major Product Offerings
7.2.4 Astellas Pharma Technologies Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Technologies Key News & Latest Developments
7.3 Valeant Pharmaceuticals N.A
7.3.1 Valeant Pharmaceuticals N.A Company Summary
7.3.2 Valeant Pharmaceuticals N.A Business Overview
7.3.3 Valeant Pharmaceuticals N.A Anticonvulsant Drug Major Product Offerings
7.3.4 Valeant Pharmaceuticals N.A Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.3.5 Valeant Pharmaceuticals N.A Key News & Latest Developments
7.4 Bausch Health Companies
7.4.1 Bausch Health Companies Company Summary
7.4.2 Bausch Health Companies Business Overview
7.4.3 Bausch Health Companies Anticonvulsant Drug Major Product Offerings
7.4.4 Bausch Health Companies Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.4.5 Bausch Health Companies Key News & Latest Developments
7.5 Watson Laboratories
7.5.1 Watson Laboratories Company Summary
7.5.2 Watson Laboratories Business Overview
7.5.3 Watson Laboratories Anticonvulsant Drug Major Product Offerings
7.5.4 Watson Laboratories Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.5.5 Watson Laboratories Key News & Latest Developments
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Company Summary
7.6.2 Abbott Laboratories Business Overview
7.6.3 Abbott Laboratories Anticonvulsant Drug Major Product Offerings
7.6.4 Abbott Laboratories Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Laboratories Key News & Latest Developments
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Company Summary
7.7.2 Teva Pharmaceutical Industries Business Overview
7.7.3 Teva Pharmaceutical Industries Anticonvulsant Drug Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.7.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Anticonvulsant Drug Major Product Offerings
7.8.4 Johnson & Johnson Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Anticonvulsant Drug Major Product Offerings
7.9.4 Novartis AG Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Anticonvulsant Drug Major Product Offerings
7.10.4 Pfizer Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Shire Plc
7.11.1 Shire Plc Company Summary
7.11.2 Shire Plc Anticonvulsant Drug Business Overview
7.11.3 Shire Plc Anticonvulsant Drug Major Product Offerings
7.11.4 Shire Plc Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.11.5 Shire Plc Key News & Latest Developments
7.12 UCB Group
7.12.1 UCB Group Company Summary
7.12.2 UCB Group Anticonvulsant Drug Business Overview
7.12.3 UCB Group Anticonvulsant Drug Major Product Offerings
7.12.4 UCB Group Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.12.5 UCB Group Key News & Latest Developments
7.13 Huazhong Pharmaceutical Company Limited
7.13.1 Huazhong Pharmaceutical Company Limited Company Summary
7.13.2 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Business Overview
7.13.3 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Major Product Offerings
7.13.4 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.13.5 Huazhong Pharmaceutical Company Limited Key News & Latest Developments
7.14 Changzhou Siyao Pharmaceutical
7.14.1 Changzhou Siyao Pharmaceutical Company Summary
7.14.2 Changzhou Siyao Pharmaceutical Business Overview
7.14.3 Changzhou Siyao Pharmaceutical Anticonvulsant Drug Major Product Offerings
7.14.4 Changzhou Siyao Pharmaceutical Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.14.5 Changzhou Siyao Pharmaceutical Key News & Latest Developments
7.15 Shandong Xinyi Pharmaceutical
7.15.1 Shandong Xinyi Pharmaceutical Company Summary
7.15.2 Shandong Xinyi Pharmaceutical Business Overview
7.15.3 Shandong Xinyi Pharmaceutical Anticonvulsant Drug Major Product Offerings
7.15.4 Shandong Xinyi Pharmaceutical Anticonvulsant Drug Sales and Revenue in Global (2018-2023)
7.15.5 Shandong Xinyi Pharmaceutical Key News & Latest Developments
8 Global Anticonvulsant Drug Production Capacity, Analysis
8.1 Global Anticonvulsant Drug Production Capacity, 2018-2029
8.2 Anticonvulsant Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anticonvulsant Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anticonvulsant Drug Supply Chain Analysis
10.1 Anticonvulsant Drug Industry Value Chain
10.2 Anticonvulsant Drug Upstream Market
10.3 Anticonvulsant Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anticonvulsant Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report